Drug to slow early-stage Alzheimer's disease approved by Health Canada
October 28, 2025
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of Alzheimer's disease.
Unpublished Newswire
A new global health report suggests that every year from 2020 to 2024 about 1,400 deaths in Canada were associated with wildfire smoke pollution as climate change takes an increasing toll on the country’s health. The Lancet Countdown on health and climate change, compiled by more than 100 experts worldwide, is considered one of the most comprehensive looks at the subject.
October 28, 2025 - 20:38 | Jordan Omstead | The Globe and Mail
Seven obstetricians and gynecologists have resigned from Royal Inland Hospital in Kamloops, B.C., while four psychiatrists have stepped down from Vernon Jubilee Hospital.
October 28, 2025 - 20:19 | Victoria Femia | Global News - Canada
A senior official working at the Canada Revenue Agency says the agency is looking to artificial intelligence and better training to help call centre agents provide more accurate answers to taxpayers.
October 28, 2025 - 20:00 | | CBC News - Canada
Comments
Be the first to comment